Riskpilot← Back to searchSign inGet full accessBjartmarMed AB
ABActiveOrg 5593407132Ljunghustorget 6Business and other management consultancy activities · NACE 7020Est. 20211 employees
Revenue 2025
SEK 3,3M
+96% vs 2024
EBITDA margin
52.5%
+312% vs 2024
Equity ratio
91.1%
Financial strength
Net profit 2025
SEK 1,4M
+316% vs 2024
| Revenue | SEK 3,3M | +96% |
| EBITDA | SEK 1,8M | +312% |
| Net profit | SEK 1,4M | +316% |
| Total assets | SEK 2,3M | +149% |
| Equity | SEK 2,1M | +203% |
| Employees | 1 | — |
Legal name
BjartmarMed AB
Org number
5593407132
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
14 oktober 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Bjartmar, Leif Carl Ivar Bjartmar, Lisa Charlotta
Company purpose
Konsultverksamhet inom läkemedelsutveckling, hälso- och sjukvård. Medicinsk rådgivning, utbildning och fortbildning.
Address
Ljunghustorget 6
Email
carl.bjartmar@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 1 212 | 1 705 | 3 339 |
| Staff expenses | — | −722 | −1 123 | −1 153 |
| EBITDA | −2 | 414 | 425 | 1 753 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −2 | 414 | 425 | 1 753 |
| Net financials | — | 0 | 2 | 15 |
| Profit before tax | −2 | 414 | 427 | 1 768 |
| Tax | — | −85 | −91 | −371 |
| Net profit | −2 | 329 | 336 | 1 397 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 24 | 683 | 919 | 2 289 |
| Equity | 23 | 352 | 688 | 2 086 |
| Long-term debt | — | — | — | — |
| Short-term debt | 0 | 331 | 231 | 204 |
| Total debt | 0 | 331 | 231 | 204 |
EBITDA margin
52.5%
This company
15.8%
Market median
+232% vs market
20222025
Equity ratio
91.1%
This company
38.2%
Market median
+138% vs market
20222025
Return on equity
67.0%
This company
18.4%
Market median
+264% vs market
20222025
Net profit margin
41.8%
This company
8.1%
Market median
+416% vs market
20222025
Asset turnover
1.46×
This company
1.12×
Market median
+30% vs market
20222025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-14 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BjartmarMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Carl Ivar Bjartmar | Chief Executive Officer | 0 companies |
| Otto Carl Ivar Bjartmar | Board of Directors | 0 companies |
| Inessa Maria Bjartmar | Board of Directors | 0 companies |
| Lisa Charlotta Bjartmar | Chairman | 0 companies |